Taysha Gene Therapies shares owned by Morgan Stanley
Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Taysha Gene Therapies
Tip: Access up to 7 years of quarterly data
All positions including Taysha Gene Therapies held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Taysha Gene Therapies by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $39M | 17M | 2.31 |
| 2024-12-31 | $31M | 18M | 1.73 |
| 2024-09-30 | $15M | 7.7M | 2.01 |
| 2024-06-30 | $17M | 7.5M | 2.24 |
| 2024-03-31 | $15M | 5.2M | 2.87 |
| 2023-12-31 | $383k | 217k | 1.77 |
| 2023-09-30 | $544k | 172k | 3.16 |
| 2023-06-30 | $87k | 131k | 0.66 |
| 2022-12-31 | $59k | 24k | 2.50 |
| 2022-06-30 | $292k | 72k | 4.07 |
| 2022-03-31 | $1.2M | 176k | 6.59 |
| 2021-06-30 | $0 | 36k | 0.00 |
| 2020-12-31 | $831k | 31k | 26.52 |